ProShares UltraShort Bloomberg Natural Gas ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? ProShares UltraShort Bloomberg Natural Gas ETF trades at $24.67 (market cap $141.25M), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 12.3× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and Nuvation Bio Inc. Class A Common Stock is more actively traded (9,289,619 versus 5,492,367). Which is the better fit depends on your goals — on Pluang, investors hold ProShares UltraShort Bloomberg Natural Gas ETF for 10 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| KOLD | NUVB | |
|---|---|---|
Market Cap | $141.25M | $1.74B |
Volume | 5,492,367 | 9,289,619 |
Sector | Leveraged / Inverse | Health |
52-Week High | $49.39 | $9.54 |
52-Week Low | $13.58 | $3.41 |
Typical Hold Time | 10 Days | 1 Days |
Enterprise Value | — | $1.33B |
Signals from Pluang's Aura AI — not financial advice
KOLD is trading at $24.475, down 1.47% on the day, with a bearish technical outlook as moving averages signal strong selling pressure. The stock faces headwinds from record-high natural gas production and mild weather forecasts that are weighing on energy sector sentiment. Recent news highlights geopolitical tensions in the Middle East and supply dynamics affecting natural gas markets, creating volatility for energy-related investments.
The outlook remains cautious given the bearish technical indicators and fundamental pressures from oversupply conditions in natural gas markets. Investment opportunities exist for contrarian investors betting on geopolitical risk premiums, but risks include continued production growth and weather-dependent demand uncertainty that could pressure energy sector performance in the near term.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →